2bf9 › Citations

Conformational flexibility in a small globular hormone: x-ray analysis of avian pancreatic polypeptide at 0.98-A resolution.

Glover I, Haneef I, Pitts J, Wood S, Moss D, Tickle I, Blundell T
Biopolymers 22 293-304 (1983)
Cited: 115 times
EuropePMC logo PMID: 6673760

Articles - 2bf9 mentioned but not cited (15)

  1. Persistent homology analysis of protein structure, flexibility, and folding. Xia K, Wei GW. Int J Numer Method Biomed Eng 30 814-844 (2014)
  2. Fast and anisotropic flexibility-rigidity index for protein flexibility and fluctuation analysis. Opron K, Xia K, Wei GW. J Chem Phys 140 234105 (2014)
  3. Surveying protein structure and function using bis-arsenical small molecules. Scheck RA, Schepartz A. Acc. Chem. Res. 44 654-665 (2011)
  4. Hydration water and bulk water in proteins have distinct properties in radial distributions calculated from 105 atomic resolution crystal structures. Chen X, Weber I, Harrison RW. J Phys Chem B 112 12073-12080 (2008)
  5. On the Dielectric Boundary in Poisson-Boltzmann Calculations. Tjong H, Zhou HX. J Chem Theory Comput 4 507-514 (2008)
  6. In vivo enrichment of genetically manipulated platelets corrects the murine hemophilic phenotype and induces immune tolerance even using a low multiplicity of infection. Schroeder JA, Chen Y, Fang J, Wilcox DA, Shi Q. J. Thromb. Haemost. 12 1283-1293 (2014)
  7. Coarse grained normal mode analysis vs. refined Gaussian Network Model for protein residue-level structural fluctuations. Park JK, Jernigan R, Wu Z. Bull. Math. Biol. 75 124-160 (2013)
  8. The Role of Aromatic Residues in Stabilizing the Secondary and Tertiary Structure of Avian Pancreatic Polypeptide. Palermo NY, Csontos J, Murphy RF, Lovas S. Int J Quantum Chem 108 814-819 (2008)
  9. Molecular nonlinear dynamics and protein thermal uncertainty quantification. Xia K, Wei GW. Chaos 24 013103 (2014)
  10. Blind prediction of protein B-factor and flexibility. Bramer D, Wei GW. J Chem Phys 149 134107 (2018)
  11. Evaluation of methods to cap molecular fragments in calculating energies of interaction in avian pancreatic polypeptide. Hatfield MP, Palermo NY, Csontos J, Murphy RF, Lovas S. Int J Quantum Chem 108 1017-1021 (2008)
  12. Identification of new, well-populated amino-acid sidechain rotamers involving hydroxyl-hydrogen atoms and sulfhydryl-hydrogen atoms. Ho BK, Agard DA. BMC Struct. Biol. 8 41 (2008)
  13. A new density-modification procedure extending the application of the recent |ρ|-based phasing algorithm to larger crystal structures. Rius J, Torrelles X. Acta Crystallogr A Found Adv 77 339-347 (2021)
  14. Atom-specific persistent homology and its application to protein flexibility analysis. Bramer D, Wei GW. Comput Math Biophys 8 1-35 (2020)
  15. Identification and characterization of a large family of superbinding bacterial SH2 domains. Kaneko T, Stogios PJ, Ruan X, Voss C, Evdokimova E, Skarina T, Chung A, Liu X, Li L, Savchenko A, Ensminger AW, Li SS. Nat Commun 9 4549 (2018)


Reviews citing this publication (17)

  1. Hormonal regulation of food intake. Stanley S, Wynne K, McGowan B, Bloom S. Physiol. Rev. 85 1131-1158 (2005)
  2. Strategies for targeting protein-protein interactions with synthetic agents. Yin H, Hamilton AD. Angew. Chem. Int. Ed. Engl. 44 4130-4163 (2005)
  3. Neuropeptide families and their receptors: evolutionary perspectives. Hoyle CH. Brain Res. 848 1-25 (1999)
  4. Structure and receptor binding of PYY analogs. Keire DA, Bowers CW, Solomon TE, Reeve JR. Peptides 23 305-321 (2002)
  5. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors. Beck-Sickinger AG, Jung G. Biopolymers 37 123-142 (1995)
  6. Mapping protein dynamics by X-ray diffraction. Ringe D, Petsko GA. Prog. Biophys. Mol. Biol. 45 197-235 (1985)
  7. Neuropeptide Y and sleep. Dyzma M, Boudjeltia KZ, Faraut B, Kerkhofs M. Sleep Med Rev 14 161-165 (2010)
  8. The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control. Wynne K, Bloom SR. Nat Clin Pract Endocrinol Metab 2 612-620 (2006)
  9. Obesity treatment: novel peripheral targets. Field BC, Chaudhri OB, Bloom SR. Br J Clin Pharmacol 68 830-843 (2009)
  10. Recent developments in the theory of protein folding: searching for the global energy minimum. Scheraga HA. Biophys. Chem. 59 329-339 (1996)
  11. Proteins at atomic resolution. Dauter Z, Lamzin VS, Wilson KS. Curr. Opin. Struct. Biol. 5 784-790 (1995)
  12. Design of alpha-helical peptides: their role in protein folding and molecular biology. Parthasarathy R, Chaturvedi S, Go K. Prog. Biophys. Mol. Biol. 64 1-54 (1995)
  13. Anticonvulsant neuropeptides as drug leads for neurological diseases. Robertson CR, Flynn SP, White HS, Bulaj G. Nat Prod Rep 28 741-762 (2011)
  14. Neuropeptide Y receptors: autoradiographic distribution in the brain and structure-activity relationships. Quirion R, Martel JC, Dumont Y, Cadieux A, Jolicoeur F, St-Pierre S, Fournier A. Ann. N. Y. Acad. Sci. 611 58-72 (1990)
  15. Gut hormones as potential new targets for appetite regulation and the treatment of obesity. Field BC, Wren AM, Cooke D, Bloom SR. Drugs 68 147-163 (2008)
  16. Constrained peptides as miniature protein structures. Yin H. ISRN Biochem 2012 692190 (2012)
  17. Peptides in apoptosis research. Salgado J, García-Sáez AJ, Malet G, Mingarro I, Pérez-Payá E. J. Pept. Sci. 8 543-560 (2002)

Articles citing this publication (83)

  1. Structure of papain refined at 1.65 A resolution. Kamphuis IG, Kalk KH, Swarte MB, Drenth J. J. Mol. Biol. 179 233-256 (1984)
  2. Structure of bovine pancreatic trypsin inhibitor. Results of joint neutron and X-ray refinement of crystal form II. Wlodawer A, Walter J, Huber R, Sjölin L. J. Mol. Biol. 180 301-329 (1984)
  3. Hydrogen bonding in globular proteins. Stickle DF, Presta LG, Dill KA, Rose GD. J. Mol. Biol. 226 1143-1159 (1992)
  4. Identification of native protein folds amongst a large number of incorrect models. The calculation of low energy conformations from potentials of mean force. Hendlich M, Lackner P, Weitckus S, Floeckner H, Froschauer R, Gottsbacher K, Casari G, Sippl MJ. J. Mol. Biol. 216 167-180 (1990)
  5. Solvent-induced distortions and the curvature of alpha-helices. Blundell T, Barlow D, Borkakoti N, Thornton J. Nature 306 281-283 (1983)
  6. Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax. Baranger AM, Palmer CR, Hamm MK, Giebler HA, Brauweiler A, Nyborg JK, Schepartz A. Nature 376 606-608 (1995)
  7. Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations. Beck-Sickinger AG, Wieland HA, Wittneben H, Willim KD, Rudolf K, Jung G. Eur. J. Biochem. 225 947-958 (1994)
  8. Reduced representation model of protein structure prediction: statistical potential and genetic algorithms. Sun S. Protein Sci. 2 762-785 (1993)
  9. Molecular structure of mammalian neuropeptide Y: analysis by molecular cloning and computer-aided comparison with crystal structure of avian homologue. Allen J, Novotný J, Martin J, Heinrich G. Proc. Natl. Acad. Sci. U.S.A. 84 2532-2536 (1987)
  10. Conformational studies on the pancreatic polypeptide hormone family. Glover ID, Barlow DJ, Pitts JE, Wood SP, Tickle IJ, Blundell TL, Tatemoto K, Kimmel JR, Wollmer A, Strassburger W. Eur. J. Biochem. 142 379-385 (1984)
  11. Identification and molecular cloning of a neuropeptide Y homolog that produces prolonged inhibition in Aplysia neurons. Rajpara SM, Garcia PD, Roberts R, Eliassen JC, Owens DF, Maltby D, Myers RM, Mayeri E. Neuron 9 505-513 (1992)
  12. Prediction of protein conformation on the basis of a search for compact structures: test on avian pancreatic polypeptide. Liwo A, Pincus MR, Wawak RJ, Rackovsky S, Scheraga HA. Protein Sci. 2 1715-1731 (1993)
  13. Structure determination of racemic trichogin A IV using centrosymmetric crystals. Toniolo C, Peggion C, Crisma M, Formaggio F, Shui X, Eggleston DS. Nat. Struct. Biol. 1 908-914 (1994)
  14. Efficient Monte Carlo method for simulation of fluctuating conformations of native proteins. Noguti T, Go N. Biopolymers 24 527-546 (1985)
  15. Sequence and molecular characterization of a multicopy invasion plasmid antigen gene, ipaH, of Shigella flexneri. Hartman AB, Venkatesan M, Oaks EV, Buysse JM. J. Bacteriol. 172 1905-1915 (1990)
  16. Highly potent and small neuropeptide Y agonist obtained by linking NPY 1-4 via spacer to alpha-helical NPY 25-36. Beck A, Jung G, Gaida W, Köppen H, Lang R, Schnorrenberg G. FEBS Lett. 244 119-122 (1989)
  17. Simulations of proteins in water. Berendsen HJ, Van Gunsteren WF, Zwinderman HR, Geurtsen RG. Ann. N. Y. Acad. Sci. 482 269-286 (1986)
  18. Neuropeptide Y in guinea pig, rabbit, rat and man. Identical amino acid sequence and oxidation of methionine-17. O'Hare MM, Tenmoku S, Aakerlund L, Hilsted L, Johnsen A, Schwartz TW. Regul. Pept. 20 293-304 (1988)
  19. Molecular recognition of protein surfaces: high affinity ligands for the CBP KIX domain. Rutledge SE, Volkman HM, Schepartz A. J. Am. Chem. Soc. 125 14336-14347 (2003)
  20. Solution conformation of human neuropeptide Y by 1H nuclear magnetic resonance and restrained molecular dynamics. Darbon H, Bernassau JM, Deleuze C, Chenu J, Roussel A, Cambillau C. Eur. J. Biochem. 209 765-771 (1992)
  21. Molecular cloning and characterization of an invertebrate homologue of a neuropeptide Y receptor. Tensen CP, Cox KJ, Burke JF, Leurs R, van der Schors RC, Geraerts WP, Vreugdenhil E, Heerikhuizen H. Eur. J. Neurosci. 10 3409-3416 (1998)
  22. Molecular dynamics studied by analysis of the X-ray diffuse scattering from lysozyme crystals. Doucet J, Benoit JP. Nature 325 643-646 (1987)
  23. NPY in invertebrates: molecular answers to altered functions during evolution. de Jong-Brink M, ter Maat A, Tensen CP. Peptides 22 309-315 (2001)
  24. Design and Evolution of a Miniature Bcl-2 Binding Protein We thank the HHMI Biopolymer/Keck Foundation Biotechnology Resource Laboratory (Yale University School of Medicine, New Haven, CT) for oligonucleotide and peptide synthesis and amino acid analysis and Professor Jennifer Doudna (Yale University) for use of a Perseptive Voyager-DE (MALDI-TOF) mass spectrometer. We are grateful also to Dr. Junying Yuan and Dr. Alexi Degterev (Harvard Medical School) for a generous gift of Bcl-X(L)-His(6) and Stacey E. Rutledge for helpful comments. This work was supported by the National Institutes of Health. Chin JW, Schepartz A. Angew. Chem. Int. Ed. Engl. 40 3806-3809 (2001)
  25. Metal ion-induced conformational changes of phosphorylated fragments of human neurofilament (NF-M) protein. Hollósi M, Urge L, Perczel A, Kajtár J, Teplán I, Otvös L, Fasman GD. J. Mol. Biol. 223 673-682 (1992)
  26. Neuropeptide Y receptor subtype with unique properties cloned in the zebrafish: the zYa receptor. Starbäck P, Lundell I, Fredriksson R, Berglund MM, Yan YL, Wraith A, Söderberg C, Postlethwait JH, Larhammar D. Brain Res. Mol. Brain Res. 70 242-252 (1999)
  27. Receptors on phaeochromocytoma cells for two members of the PP-fold family--NPY and PP. Schwartz TW, Sheikh SP, O'Hare MM. FEBS Lett. 225 209-214 (1987)
  28. Signal epitopes in the three-dimensional structure of neuropeptide Y. Interaction with Y1, Y2, and pancreatic polypeptide receptors. Schwartz TW, Fuhlendorff J, Kjems LL, Kristensen MS, Vervelde M, O'Hare M, Krstenansky JL, Bjørnholm B. Ann. N. Y. Acad. Sci. 611 35-47 (1990)
  29. Centrally truncated and stabilized porcine neuropeptide Y analogs: design, synthesis, and mouse brain receptor binding. Krstenansky JL, Owen TJ, Buck SH, Hagaman KA, McLean LR. Proc. Natl. Acad. Sci. U.S.A. 86 4377-4381 (1989)
  30. The synthesis, physical characterization and receptor binding affinity of neuropeptide Y (NPY). Krstenansky JL, Buck SH. Neuropeptides 10 77-85 (1987)
  31. Neuropeptide Y. Optimized solid-phase synthesis and conformational analysis in trifluoroethanol. Mierke DF, Dürr H, Kessler H, Jung G. Eur. J. Biochem. 206 39-48 (1992)
  32. 2-36[K4,RYYSA(19-23)]PP a novel Y5-receptor preferring ligand with strong stimulatory effect on food intake. McCrea K, Wisialowski T, Cabrele C, Church B, Beck-Sickinger A, Kraegen E, Herzog H. Regul. Pept. 87 47-58 (2000)
  33. Delineation of conformational preferences in human salivary statherin by 1H, 31P NMR and CD studies: sequential assignment and structure-function correlations. Naganagowda GA, Gururaja TL, Levine MJ. J. Biomol. Struct. Dyn. 16 91-107 (1998)
  34. A comparison of the structure and dynamics of avian pancreatic polypeptide hormone in solution and in the crystal. Krüger P, Strassburger W, Wollmer A, van Gunsteren WF. Eur. Biophys. J. 13 77-88 (1985)
  35. Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2 receptor. Rist B, Zerbe O, Ingenhoven N, Scapozza L, Peers C, Vaughan PF, McDonald RL, Wieland HA, Beck-Sickinger AG. FEBS Lett. 394 169-173 (1996)
  36. Release of PYY from pig intestinal mucosa; luminal and neural regulation. Sheikh SP, Holst JJ, Orskov C, Ekman R, Schwartz TW. Regul. Pept. 26 253-266 (1989)
  37. Herpesvirus protease inhibition by dimer disruption. Shimba N, Nomura AM, Marnett AB, Craik CS. J. Virol. 78 6657-6665 (2004)
  38. High-performance liquid chromatography of amino acids, peptides and proteins. CXXVIII. Effect of D-amino acid substitutions on the reversed-phase high-performance liquid chromatography retention behaviour of neuropeptide Y[18-36] analogues. Aguilar MI, Mougos S, Boublik J, Rivier J, Hearn MT. J. Chromatogr. 646 53-65 (1993)
  39. Neuropeptide Y and neuropeptide Y18-36. Structural and biological characterization. Boublik J, Scott N, Taulane J, Goodman M, Brown M, Rivier J. Int J Pept Protein Res 33 11-15 (1989)
  40. Neuropeptide Y: identification of the binding site. Beck-Sickinger AG, Gaida W, Schnorrenberg G, Lang R, Jung G. Int J Pept Protein Res 36 522-530 (1990)
  41. Analysis of structure-function relationships of neuropeptide Y using molecular dynamics simulations and pharmacological activity and binding measurements. MacKerell AD, Hemsén A, Lacroix JS, Lundberg JM. Regul. Pept. 25 295-313 (1989)
  42. A 1.8 A resolution potential function for protein folding. Crippen GM, Snow ME. Biopolymers 29 1479-1489 (1990)
  43. A genetic algorithm that seeks native states of peptides and proteins. Sun S. Biophys. J. 69 340-355 (1995)
  44. Ca(2+)-induced conformational transitions of phosphorylated peptides. Hollósi M, Otvös L, Urge L, Kajtár J, Perczel A, Laczkó I, Vadász Z, Fasman GD. Biopolymers 33 497-510 (1993)
  45. The structure of the double-stranded RNA pentamer 5'(CACAG) . 5'(CUGUG) determined by nuclear Overhauser enhancement measurements: interproton distance determination and structure refinement on the basis of X-ray coordinates. Clore GM, Gronenborn AM, McLaughlin LW. Eur. J. Biochem. 151 153-165 (1985)
  46. Investigation of de novo totally random biosequences, Part I: A general method for in vitro selection of folded domains from a random polypeptide library displayed on phage. Chiarabelli C, Vrijbloed JW, Thomas RM, Luisi PL. Chem. Biodivers. 3 827-839 (2006)
  47. Simulating the folding of small proteins by use of the local minimum energy and the free solvation energy yields native-like structures. Brasseur R. J Mol Graph 13 312-322 (1995)
  48. Fluorescent labelled analogues of neuropeptide Y for the characterization of cells expressing NPY receptor subtypes. Ingenhoven N, Beck-Sickinger AG. J. Recept. Signal Transduct. Res. 17 407-418 (1997)
  49. Correlation of beta-bend conformations of tetrapeptides with their activities in CD4-receptor binding assays. Shah D, Chen JM, Carty RP, Pincus MR, Scheraga HA. Int J Pept Protein Res 34 325-332 (1989)
  50. Simultaneous and coupled energy optimization of homologous proteins: a new tool for structure prediction. Keasar C, Elber R, Skolnick J. Fold Des 2 247-259 (1997)
  51. Analysis of pancreatic polypeptide cDNA from the house musk shrew, Suncus murinus, suggests a phylogenetically closer relationship with humans than for other small laboratory animal species. Hoyle CH, Hill J, Sanger GJ, Andrews PL. Regul. Pept. 114 137-144 (2003)
  52. Coupling the folding of homologous proteins. Keasar C, Tobi D, Elber R, Skolnick J. Proc. Natl. Acad. Sci. U.S.A. 95 5880-5883 (1998)
  53. Molecular modeling and dynamics of neuropeptide Y. MacKerell AD. J. Comput. Aided Mol. Des. 2 55-63 (1988)
  54. The effect of C-terminal helix stabilization on specific DNA binding by monomeric GCN4 peptides. Zhang M, Wu B, Zhao H, Taylo JW. J. Pept. Sci. 8 125-136 (2002)
  55. Biologically active neuropeptide Y analogs. Boublik JH, Spicer MA, Scott NA, Brown MR, Rivier JE. Ann. N. Y. Acad. Sci. 611 27-34 (1990)
  56. Primary B-cell response to neuropeptide Y and bovine pancreatic polypeptide. Deng YJ, Chua MM, Andrews GC, Karush F. Mol. Immunol. 29 847-856 (1992)
  57. Structural characterizations of neuropeptide tyrosine (NPY) and its agonist analog [Ahx5-17]NPY by NMR and molecular modeling. Boulanger Y, Chen Y, Commodari F, Senécal L, Laberge AM, Fournier A, St-Pierre S. Int J Pept Protein Res 45 86-95 (1995)
  58. The contribution of helical potential to the in vitro receptor binding activity of a neuropeptide Y N-terminal deletion fragment. Doughty MB, Hu L. Biopolymers 33 1195-1206 (1993)
  59. Parametric sensitivity analysis of avian pancreatic polypeptide (APP). Zhang H, Wong CF, Thacher T, Rabitz H. Proteins 23 218-232 (1995)
  60. Conformational properties of the proline region of porcine neuropeptide Y by CD and 1H-nmr spectroscopy. Chu SS, Velde DV, Shobe D, Balse P, Doughty MB. Biopolymers 35 583-593 (1995)
  61. Necessary conditions for avoiding incorrect polypeptide folds in conformational search by energy minimization. Vajda S, Jafri MS, Sezerman OU, DeLisi C. Biopolymers 33 173-192 (1993)
  62. Three-dimensional structure of the Y1 receptor agonist [Leu31, Pro34]NPY as determined by NMR and molecular modeling. Khiat A, Labelle M, Boulanger Y. J Pept Res 51 317-322 (1998)
  63. Avian pancreatic polypeptide fragments refold to native aPP conformation when combined in solution: a CD and VCD study. Copps J, Murphy RF, Lovas S. Biopolymers 83 32-38 (2006)
  64. Centrally truncated neuropeptide Y analog acts as an agonist for Y1 receptors on SK-N-MC cells. Gordon EA, Krstenansky JL, Fishman PH. Neurosci. Lett. 119 187-190 (1990)
  65. Left-handed polyproline-II helix revisited: proteins causing proteopathies. Adzhubei AA, Anashkina AA, Makarov AA. J. Biomol. Struct. Dyn. 35 2701-2713 (2017)
  66. Molecular structure of neuropeptide Y. Allen JM. Ann. N. Y. Acad. Sci. 611 86-98 (1990)
  67. Synthesis of analogues of peptide YY with modified N-terminal regions: relationships of amphiphilic secondary structures and activity in rat vas deferens. Minakata H, Iwashita T. Biopolymers 29 61-67 (1990)
  68. A descriptive analysis of populations of three-dimensional structures calculated from primary sequences of proteins by OSIRIS. Benhabilès N, Gallet X, Thomas-Soumarmon A, Brasseur R. J. Comput. Biol. 5 351-366 (1998)
  69. An immunochemical study of avian pancreatic polypeptide: the nature of the principal epitope. Taylor TC, Thompson DO, Ebner KE, Kimmel JR, Rawitch AB. Mol. Immunol. 25 961-973 (1988)
  70. Conformational analysis of neuropeptide Y segments by CD, NMR spectroscopy and restrained molecular dynamics. Gurrath M, Bisello A, Bottazzo K, Chung CW, Mammi S, Peggion E. J. Pept. Sci. 2 176-193 (1996)
  71. Crystallization of bovine pancreatic polypeptide. Hoffman JA, Chance RE. Biochem. Biophys. Res. Commun. 116 830-835 (1983)
  72. Iodinated derivatives of the hormone avian pancreatic polypeptide. Taylor TC, Kimmel JR. Anal. Biochem. 166 194-203 (1987)
  73. Synthesis, receptor binding, and crosslinking of photoactive analogues of neuropeptide Y. Beck-Sickinger AG, Wieland HA, Brunner J. J. Recept. Signal Transduct. Res. 15 473-485 (1995)
  74. Troubleshooting Carry-Over in the LC-MS Analysis of Biomolecules: The Case of Neuropeptide Y. Yamagaki T, Yamazaki T. Mass Spectrom (Tokyo) 8 S0083 (2019)
  75. Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide Y Y1 receptor antagonists. Dove S, Michel MC, Knieps S, Buschauer A. Can. J. Physiol. Pharmacol. 78 108-115 (2000)
  76. The NMR-derived conformation of neuropeptide F from Moniezia expansa. Miskolzie M, Kotovych G. J. Biomol. Struct. Dyn. 19 991-998 (2002)
  77. The solution structure of pGolemi, a high affinity Mena EVH1 binding miniature protein, suggests explanations for paralog-specific binding to Ena/VASP homology (EVH) 1 domains. Link NM, Hunke C, Mueller JW, Eichler J, Bayer P. Biol. Chem. 390 417-426 (2009)
  78. Autonomous Sequences in Myoglobin Emerging from X-ray Structure of Holomyoglobin. Narita M, Narita M, Itsuno Y, Itsuno S. ACS Omega 4 992-999 (2019)
  79. Echinoderms provide missing link in the evolution of PrRP/sNPF-type neuropeptide signalling. Yañez-Guerra LA, Zhong X, Moghul I, Butts T, Zampronio CG, Jones AM, Mirabeau O, Elphick MR. Elife 9 (2020)
  80. Grafting miniature DNA binding proteins. Pflum MK. Chem. Biol. 11 3-4 (2004)
  81. Protein Backbone Alteration in Non-Hairpin β-Turns: Impacts on Tertiary Folded Structure and Folded Stability. Harmon TW, Horne WS. Chembiochem 24 e202300113 (2023)
  82. Resonant recognition model of neuropeptide Y family: hot spot amino acid distribution in the sequences. Murakami M. J Protein Chem 19 609-613 (2000)
  83. Theoretical Characterization of the Long-range Attraction between G-actin Molecules through the Excluded Volume Effect. Irisa M. J Biol Phys 28 347-357 (2002)


Related citations provided by authors (5)

  1. Crystal Structure Analysis of Avian Pancreatic Polypeptide at 1.37 Angstroms Resolution. Pitts JE, Tickle IJ, Wood SP, Blundell TL Kristallografiya 27 97- (1982)
  2. Crystal Structure Analysis of Avian Pancreatic Polypeptide at 1.37 Angstroms Resolution. Pitts JE, Tickle IJ, Wood SP, Blundell TL Sov. Phys. Crystallogr. 27 56- (1982)
  3. X-ray analysis (1. 4-A resolution) of avian pancreatic polypeptide: Small globular protein hormone.. Blundell TL, Pitts JE, Tickle IJ, Wood SP, Wu CW Proc Natl Acad Sci U S A 78 4175-9 (1981)
  4. Purification, crystallisation and preliminary X-ray studies on avian pancreatic polypeptide.. Wood SP, Pitts JE, Blundell TL, Tickle IJ, Jenkins JA Eur J Biochem 78 119-26 (1977)
  5. Isolation and characterization of a new pancreatic polypeptide hormone.. Kimmel JR, Hayden LJ, Pollock HG J Biol Chem 250 9369-76 (1975)

Quick links